Cite
HARVARD Citation
Leifer, E. et al. (2019). Discussion of "A Hybrid Phase I‐II/III Clinical Trial Design Allowing Dose Re‐Optimization in Phase III" by Andrew G. Chapple and Peter F. Thall. Biometrics. 75 (2), pp. 382-384. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Leifer, E. et al. (2019). Discussion of "A Hybrid Phase I‐II/III Clinical Trial Design Allowing Dose Re‐Optimization in Phase III" by Andrew G. Chapple and Peter F. Thall. Biometrics. 75 (2), pp. 382-384. [Online].